These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26908847)

  • 41. A new epidemic.
    Pradhan MC
    J Indian Med Assoc; 1996 Sep; 94(9):326-7, 333. PubMed ID: 9019075
    [No Abstract]   [Full Text] [Related]  

  • 42. Hypothyroidism in a patient receiving treatment for multidrug-resistant tuberculosis.
    Soumakis SA; Berg D; Harris HW
    Clin Infect Dis; 1998 Oct; 27(4):910-1. PubMed ID: 9798062
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug-induced hypothyroidism in patients receiving treatment for multidrug-resistant tuberculosis in the UK.
    Gupta J; Breen RA; Milburn HJ
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1278. PubMed ID: 22871328
    [No Abstract]   [Full Text] [Related]  

  • 44. Is there still room for therapeutic drug monitoring of linezolid in patients with tuberculosis?
    Cattaneo D; Gervasoni C; Clementi E
    Eur Respir J; 2016 Apr; 47(4):1287-8. PubMed ID: 27037318
    [No Abstract]   [Full Text] [Related]  

  • 45. Is there still room for therapeutic drug monitoring of linezolid in patients with tuberculosis?
    Bolhuis MS; Tiberi S; Sotgiu G; De Lorenzo S; Kosterink JG; van der Werf TS; Migliori GB; Alffenaar JW
    Eur Respir J; 2016 Apr; 47(4):1288-90. PubMed ID: 27037319
    [No Abstract]   [Full Text] [Related]  

  • 46. A step forward in the treatment of multidrug-resistant tuberculosis.
    Ridzon R; Castro KG
    Int J Tuberc Lung Dis; 2019 May; 23(5):533-534. PubMed ID: 31097059
    [No Abstract]   [Full Text] [Related]  

  • 47. Outcomes of pulmonary MDR-TB: impacts of fluoroquinolone resistance and linezolid treatment.
    Jeong BH; Jeon K; Park HY; Kwon OJ; Lee KS; Kim HK; Choi YS; Kim J; Huh HJ; Lee NY; Koh WJ
    J Antimicrob Chemother; 2015 Nov; 70(11):3127-33. PubMed ID: 26203184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypothyroidism due to ethionamide.
    McDonnell ME; Braverman LE; Bernardo J
    N Engl J Med; 2005 Jun; 352(26):2757-9. PubMed ID: 15987931
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring: first experiences with sub-300 mg linezolid dosages using in-house made capsules.
    Bolhuis MS; van der Werf TS; Kerstjens HAM; de Lange WCM; Alffenaar JC; Akkerman OW
    Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31439686
    [No Abstract]   [Full Text] [Related]  

  • 50. Linezolid in the treatment of drug-resistant tuberculosis: the way forward?
    Yew WW; Lange C
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):631-2. PubMed ID: 24903928
    [No Abstract]   [Full Text] [Related]  

  • 51. Drug susceptibility of tuberculosis isolates in Kansas, 1992-1993.
    Kans Med; 1994 Jun; 95(6):147-8. PubMed ID: 7933767
    [No Abstract]   [Full Text] [Related]  

  • 52. Evolving strategies for dose optimization of linezolid for treatment of tuberculosis.
    Nuermberger E
    Int J Tuberc Lung Dis; 2016 Dec; 20(12):48-51. PubMed ID: 28240573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Linezolid for the treatment of multidrug-resistant tuberculosis.
    Fortún J; Martín-Dávila P; Navas E; Pérez-Elías MJ; Cobo J; Tato M; De la Pedrosa EG; Gómez-Mampaso E; Moreno S
    J Antimicrob Chemother; 2005 Jul; 56(1):180-5. PubMed ID: 15911549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The treatment of drug resistant tuberculosis.
    Nardini S
    Monaldi Arch Chest Dis; 1994 Jun; 49(3):269-70. PubMed ID: 8087130
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of multidrug-resistant tuberculosis: definition of the outcome 'failure'.
    Chiang CY; Van Deun A; Trébucq A; Heldal E; Caminero JA; Aït-Khaled N
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):4-5. PubMed ID: 21276289
    [No Abstract]   [Full Text] [Related]  

  • 56. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB; Jiang RH; Li L; Xiao HP
    Int J Tuberc Lung Dis; 2012; 16(3):358-63. PubMed ID: 22640450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ethionamide-induced hypothyroidism.
    Dutta BS; Hassan G; Waseem Q; Saheer S; Singh A
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):141. PubMed ID: 22236862
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY; Bilgin K; Uzun M; Durupinar B
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reaction to cheese during TB treatment.
    Carvalho AC; Manfrin M; Gore RP; Capone S; Scalvini A; Armellini A; Giovine T; Carosi G; Matteelli A
    Thorax; 2004 Jul; 59(7):635. PubMed ID: 15223879
    [No Abstract]   [Full Text] [Related]  

  • 60. Expanding the evidence base supporting shorter treatment durations for multidrug-resistant tuberculosis.
    Nuermberger E; Yew WW
    Int J Tuberc Lung Dis; 2015 May; 19(5):497-8. PubMed ID: 25868013
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.